Revision History
Chai Discovery · 6 revisions
Sizes are character counts of the article source. The signed number is the change from the previous revision.
Recent edit summaries
Detailed summaries recorded by editors. Generic maintenance summaries are omitted here; every recorded revision remains below. Dates describe the edit, not necessarily the event it covers.
- Correction: fixed seed-round lead investors (Thrive, OpenAI and Dimension per the company) and removed an unverified ~$150M seed valuation; moved the 86% developability figure to the November 2025 study it comes from; repointed the origin-story citation to TechCrunch's January 2026 article. Update: added the $400M Series C at $3.8B (July 2026), Chai-3, the November 2025 Chai-2 antibody study, and 2026 partnerships with Lilly, Pfizer, Novartis, argenx, BMS and GSK.
Version 5 · Oct 27, 2026, 07:21 AM
- Improve internal links (2026-10-13)
Version 4 · Oct 13, 2026, 10:13 AM
- Added 6 contextual internal links
Version 3 · Jul 23, 2026, 04:04 PM